Overview

Effect of Oseltamivir on Cognitive Function in Subjects With Influenza

Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
This study has been designed to determine if subjects treated with oseltamivir in addition to standard of care treatment for influenza demonstrate a greater improvement in attention / working memory / processing speed / mood as compared to subjects receiving standard of care alone. The cognitive tests employed are objective measures developed and administered online by HeadMinder Inc.
Phase:
Phase 4
Details
Lead Sponsor:
Trial Management Group Inc.
Collaborator:
Hoffmann-La Roche
Treatments:
Oseltamivir